Asensus surgical announces purchase of senhance robotic system by loginov moscow clinical scientific center

Research triangle park, n.c.--(business wire)--asensus surgical, inc. (nyse american: asxc), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of performance-guided surgery™, today announced that loginov moscow clinical scientific center, located in moscow, russia, has initiated its senhance® robotic surgery program following the purchase of a senhance surgical system. the installation represents the first senhance surgical system
ASXC Ratings Summary
ASXC Quant Ranking